Compugen Ltd. (CGEN) vs Cartesian Therapeutics, Inc. (RNAC)

A side-by-side comparison of Compugen Ltd. and Cartesian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CGEN vs RNAC

growth of $100 · dividends reinvested · last 10y
CGEN -63.7% (-9.6%/yr)RNAC -98.4% (-33.9%/yr)CGEN compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020182020202220242026$36$2
CGEN RNAC

CGEN vs RNAC: by the numbers

  • •CGEN is the larger company ($211M vs $203M market cap).
  • •CGEN is profitable (47.55% net margin) while RNAC runs a net loss (-10422.48%).
  • •CGEN grew revenue faster over the past five years (105.91% vs -50.01% CAGR).

Metrics side by side

Valuation

MetricCGENRNAC
P/E ratio5.95N/A
P/S ratio2.86137.71
P/B ratio2.38N/A

Profitability

MetricCGENRNAC
Gross margin86.89%100.00%
Operating margin40.94%-3099.93%
Net margin47.55%-10422.48%
ROE39.66%N/A
ROIC26.14%-33.10%

Growth (annualized)

MetricCGENRNAC
Revenue CAGR (5Y)105.91%-50.01%
Total return CAGR (5Y)-18.39%-44.03%

Frequently asked

Which has grown faster, CGEN or RNAC?
Over the past five years, CGEN grew revenue faster — CGEN at a 105.91% CAGR versus RNAC at -50.01%.
Is CGEN or RNAC more profitable?
CGEN runs the higher net margin — CGEN at 47.55% versus RNAC at -10422.48%.
How have CGEN and RNAC total returns compared?
Over the past 10 years, CGEN delivered -9.42% and RNAC delivered -33.65% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.